FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS
Yawei Liu(The First People's Hospital of Shunde), Shohreh Issazadeh‐Navikas(University of Copenhagen), Xudong Wu(Tianjin Medical University General Hospital), Kristian Helin(University of Copenhagen), Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya), JunYang Wang(University of Copenhagen), Belinda Carrión(University of Copenhagen), Morten Hanefeld Dziegiel(University of Copenhagen), Michael Kosicki(Palo Alto Institute), Per Soelberg Sørensen(University of Copenhagen), R. Carlsson(University of Copenhagen), Manuel Comabella(Universitat Autònoma de Barcelona), Maruf Hasan(University of Copenhagen), Finn Sellebjerg(Kaiser Permanente)
Cited by 159
Related Papers
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
|The Lancet|2020|29.1k
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k